全文获取类型
收费全文 | 64664篇 |
免费 | 4522篇 |
国内免费 | 213篇 |
专业分类
耳鼻咽喉 | 807篇 |
儿科学 | 1417篇 |
妇产科学 | 854篇 |
基础医学 | 8243篇 |
口腔科学 | 958篇 |
临床医学 | 6869篇 |
内科学 | 13945篇 |
皮肤病学 | 792篇 |
神经病学 | 6564篇 |
特种医学 | 2201篇 |
外国民族医学 | 5篇 |
外科学 | 11534篇 |
综合类 | 632篇 |
一般理论 | 48篇 |
预防医学 | 4403篇 |
眼科学 | 1232篇 |
药学 | 4453篇 |
中国医学 | 74篇 |
肿瘤学 | 4368篇 |
出版年
2024年 | 64篇 |
2023年 | 500篇 |
2022年 | 872篇 |
2021年 | 2014篇 |
2020年 | 1214篇 |
2019年 | 1814篇 |
2018年 | 2197篇 |
2017年 | 1537篇 |
2016年 | 1635篇 |
2015年 | 1879篇 |
2014年 | 2711篇 |
2013年 | 3377篇 |
2012年 | 5272篇 |
2011年 | 5470篇 |
2010年 | 2937篇 |
2009年 | 2702篇 |
2008年 | 4412篇 |
2007年 | 4505篇 |
2006年 | 4287篇 |
2005年 | 4109篇 |
2004年 | 3654篇 |
2003年 | 3483篇 |
2002年 | 3125篇 |
2001年 | 441篇 |
2000年 | 343篇 |
1999年 | 407篇 |
1998年 | 620篇 |
1997年 | 486篇 |
1996年 | 384篇 |
1995年 | 328篇 |
1994年 | 290篇 |
1993年 | 272篇 |
1992年 | 211篇 |
1991年 | 176篇 |
1990年 | 137篇 |
1989年 | 121篇 |
1988年 | 127篇 |
1987年 | 108篇 |
1986年 | 96篇 |
1985年 | 86篇 |
1984年 | 121篇 |
1983年 | 104篇 |
1982年 | 113篇 |
1981年 | 106篇 |
1980年 | 113篇 |
1979年 | 54篇 |
1978年 | 52篇 |
1977年 | 47篇 |
1976年 | 36篇 |
1974年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype 下载免费PDF全文
994.
Exome sequencing reveals compound heterozygous mutations in ATP8B1 in a JAG1/NOTCH2 mutation‐negative patient with clinically diagnosed Alagille syndrome 下载免费PDF全文
995.
Thomas E. Kraft Christopher Armstrong Monique R. Heitmeier Audrey R. Odom Paul W. Hruz 《Antimicrobial agents and chemotherapy》2015,59(10):6203-6209
Malaria and HIV infection are coendemic in a large portion of the world and remain a major cause of morbidity and mortality. Growing resistance of Plasmodium species to existing therapies has increased the need for new therapeutic approaches. The Plasmodium glucose transporter PfHT is known to be essential for parasite growth and survival. We have previously shown that HIV protease inhibitors (PIs) act as antagonists of mammalian glucose transporters. While the PI lopinavir is known to have antimalarial activity, the mechanism of action is unknown. We report here that lopinavir blocks glucose uptake into isolated malaria parasites at therapeutically relevant drug levels. Malaria parasites depend on a constant supply of glucose as their primary source of energy, and decreasing the available concentration of glucose leads to parasite death. We identified the malarial glucose transporter PfHT as a target for inhibition by lopinavir that leads to parasite death. This discovery provides a mechanistic basis for the antimalarial effect of lopinavir and provides a direct target for novel drug design with utility beyond the HIV-infected population. 相似文献
996.
Christopher A. Rice Beatrice L. Colon Mehmet Alp Hakan G?ker David W. Boykin Dennis E. Kyle 《Antimicrobial agents and chemotherapy》2015,59(4):2037-2044
Naegleria fowleri is a pathogenic free-living amoeba (FLA) that causes an acute fatal disease known as primary amoebic meningoencephalitis (PAM). The major problem for infections with any pathogenic FLA is a lack of effective therapeutics, since PAM has a case mortality rate approaching 99%. Clearly, new drugs that are potent and have rapid onset of action are needed to enhance the treatment regimens for PAM. Diamidines have demonstrated potency against multiple pathogens, including FLA, and are known to cross the blood-brain barrier to cure other protozoan diseases of the central nervous system. Therefore, amidino derivatives serve as an important chemotype for discovery of new drugs. In this study, we validated two new in vitro assays suitable for medium- or high-throughput drug discovery and used these for N. fowleri. We next screened over 150 amidino derivatives of multiple structural classes and identified two hit series with nM potency that are suitable for further lead optimization as new drugs for this neglected disease. These include both mono- and diamidino derivatives, with the most potent compound (DB173) having a 50% inhibitory concentration (IC50) of 177 nM. Similarly, we identified 10 additional analogues with IC50s of <1 μM, with many of these having reasonable selectivity indices. The most potent hits were >500 times more potent than pentamidine. In summary, the mono- and diamidino derivatives offer potential for lead optimization to develop new drugs to treat central nervous system infections with N. fowleri. 相似文献
997.
Parag K. Thaware Sonia McKenna Christopher C. Patterson David R. Hadden David J. Pettitt David R. McCance 《Diabetes care》2015,38(9):1701-1706
OBJECTIVE
Obesity in the offspring of women with hyperglycemia during pregnancy has been reported, but the results are conflicting. This study examined the association of hyperglycemia during pregnancy and anthropometry in 5- to 7-year-old offspring whose mothers participated in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study at the Belfast Centre.RESEARCH DESIGN AND METHODS
Women in the HAPO study underwent a 75-g oral glucose tolerance test (OGTT) at approximately 28 weeks of gestation. Mothers and caregivers remained blinded to the results unless the fasting plasma glucose (FPG) concentration was >5.8 mmol/L or the 2-h plasma glucose (2hPG) concentration was >11.1 mmol/L. Offspring weight, height, and skinfold thicknesses (triceps, subscapular, and suprailiac) were measured at age 5–7 years. Overweight, obesity, and extreme obesity were defined as a BMI z score ≥85th, ≥95th, and ≥99th percentile, respectively, based on the 1990 British Growth Standard.RESULTS
Belfast HAPO offspring (n = 1,320, 82%) aged 5–7 years attended for follow-up. With use of multiple regression, maternal FPG, 1h PG, and 2hPG did not show any relation to offspring BMI z score or offspring skinfold sum independent of maternal BMI at OGTT and offspring birth weight z score. This lack of association with maternal glycemia persisted with the offspring BMI z score expressed as ≥85th, ≥95th, or 99th percentile and the sum of skinfolds expressed as ≥90th percentile specific for sex. The initially significant relation between FPG and all offspring adiposity measures was explained by maternal BMI at the OGTT.CONCLUSIONS
After adjustment for maternal BMI at the OGTT, higher maternal FPG concentration during pregnancy (short of diabetes) is no longer a risk factor for obesity, as reflected by BMI and the sum of skinfolds in offspring aged 5–7 years. 相似文献998.
Priyathama Vellanki Rachel Bean Festus A. Oyedokun Francisco J. Pasquel Dawn Smiley Farnoosh Farrokhi Christopher Newton Limin Peng Guillermo E. Umpierrez 《Diabetes care》2015,38(4):568-574
OBJECTIVE
Clinical guidelines recommend point-of-care glucose testing and the use of supplemental doses of rapid-acting insulin before meals and at bedtime for correction of hyperglycemia. The efficacy and safety of this recommendation, however, have not been tested in the hospital setting.RESEARCH DESIGN AND METHODS
In this open-label, randomized controlled trial, 206 general medicine and surgery patients with type 2 diabetes treated with a basal-bolus regimen were randomized to receive either supplemental insulin (n = 106) at bedtime for blood glucose (BG) >7.8 mmol/L or no supplemental insulin (n = 100) except for BG >19.4 mmol/L. Point-of-care testing was performed before meals, at bedtime, and at 3:00 a.m. The primary outcome was the difference in fasting BG. In addition to the intention-to-treat analysis, an as-treated analysis was performed where the primary outcome was analyzed for only the bedtime BG levels between 7.8 and 19.4 mmol/L.RESULTS
There were no differences in mean fasting BG for the intention-to-treat (8.8 ± 2.4 vs. 8.6 ± 2.2 mmol/L, P = 0.76) and as-treated (8.9 ± 2.4 vs. 8.8 ± 2.4 mmol/L, P = 0.92) analyses. Only 66% of patients in the supplement and 8% in the no supplement groups received bedtime supplemental insulin. Hypoglycemia (BG <3.9 mmol/L) did not differ between groups for either the intention-to-treat (30% vs. 26%, P = 0.50) or the as-treated (4% vs. 8%, P = 0.37) analysis.CONCLUSIONS
The use of insulin supplements for correction of bedtime hyperglycemia was not associated with an improvement in glycemic control. We conclude that routine use of bedtime insulin supplementation is not indicated for management of inpatients with type 2 diabetes. 相似文献999.
Hannah Mathew Christopher Dittus Anita Malek Andreea Negroiu 《Clinical Case Reports》2015,3(8):714-717
We present a case of isolated congenital hyposplenism that was discovered after the peripheral smear revealed Howell‐Jolly bodies. This case serves as the basis for a review of hyposplenism for the general practitioner. 相似文献
1000.